Delos Advisors
Finance · South Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Harcourt Rd, Central, South Carolina,...Phone Number
+852 39120500Website
delos.capitalRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Delos Advisors
Delos Capital is a biotech venture capital firm founded in 2014. The company invests time and capital into life sciences companies and visionary biotech teams at all stages of development to advance medical breakthroughs and improve human health. Its investment process combines biology expertise with an analysis of unmet medical needs to support innovations in areas such as NextGen therapies, inflammatory and immunology therapeutics, mRNA-based genetic medicines, and drug discovery for obesity and metabolic disease. The firm is operated by a partnership of entrepreneurs and scientists.Explore more
Popular SearchesDelos Advisors LtdDelos Capital PartnersDelos CapitalDelos Capital 康禧全球投資基金SIC Code 67,679NAICS Code 52,523Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Delos Advisors your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Delos Advisors has new funding data
Delos Advisors, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Delos Advisors
Website visits: Recent activity has been detected on your website
Check if Delos Advisors has recently received funding, and reach out quickly before it becomes old news!
Check out if Delos Advisors is spiking on competitors!
Click to see if Delos Advisors had a recent Job posting/layoffs
Product Launch: Get notified when Delos Advisors launches new products
Earning: See what the market has to say on Delos Advisors recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Delos Advisors is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Delos Advisors is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Delos Advisors.
Delos Advisors Tech Stack
A closer look at the technologies used by Delos Advisors
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Delos Advisors News & Media
Clover Biopharmaceuticals Completes $43 Million Series B Financing
CHENGDU, China--(BUSINESS WIRE)--Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced the completion of a US$ 43 million (RMB 304 million) Series B financing. This financing round brings Clover’s total capital raised since 2016 to over US$ 100 million (over RMB 750 million). The Series B round was led by Delos Capital and Lapam Capital, with participation from Betta Capital, Sichuan Health CarClover Biopharmaceuticals Completes $43 Million Series B Financing
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.Curamir Therapeutics Launches with $10M Series A
WOBURN, MA Delos Capital announces that it has launched Curamir Therapeutics with a $10 million Series A financing.Curamir Therapeutics Raises $10M in Series A Funding
Curamir Therapeutics, a Woburn, MA-based developer of miRNA-based cancer therapeutics, raised $10M in Series A funding. The round was led by Delos Capital. Curamir Therapeutics is a biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics. Incubated through a licensing collaboration with the State University of New York (SUNY) and co-founded by Dr. Jingfang Ju, […] The post Curamir Therapeutics Raises $10M in Series A Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delos Advisors
Sign Up For FreeTo access detailed company insights
Delos Capital is a biotech venture capital firm founded in 2014. The company invests time and capital into life sciences companies and visionary biotech teams at all stages of development to advance medical breakthroughs and improve human health. Its investment process combines biology expertise with an analysis of unmet medical needs to support in... Read More
